Exercise as a multi-modal disease-modifying medicine in systemic sclerosis: An introduction by The Global Fellowship on Rehabilitation and Exercise in Systemic Sclerosis (G-FoRSS). Issue 3 (September 2021)
- Record Type:
- Journal Article
- Title:
- Exercise as a multi-modal disease-modifying medicine in systemic sclerosis: An introduction by The Global Fellowship on Rehabilitation and Exercise in Systemic Sclerosis (G-FoRSS). Issue 3 (September 2021)
- Main Title:
- Exercise as a multi-modal disease-modifying medicine in systemic sclerosis: An introduction by The Global Fellowship on Rehabilitation and Exercise in Systemic Sclerosis (G-FoRSS)
- Authors:
- Pettersson, Henrik
Alexanderson, Helene
Poole, Janet L.
Varga, Janos
Regardt, Malin
Russell, Anne-Marie
Salam, Yasser
Jensen, Kelly
Mansour, Jennifer
Frech, Tracy
Feghali-Bostwick, Carol
Varjú, Cecília
Baldwin, Nancy
Heenan, Matty
Fligelstone, Kim
Holmner, Monica
Lammi, Matthew R.
Scholand, Mary Beth
Shapiro, Lee
Volkmann, Elizabeth R.
Saketkoo, Lesley Ann - Abstract:
- Abstract: Systemic sclerosis (SSc) is a heterogeneous multisystem autoimmune disease whereby its main pathological drivers of disability and damage are vascular injury, inflammatory cell infiltration, and fibrosis. These mechanisms result in diffuse and diverse impairments arising from ischemic circulatory dysfunction leading to painful skin ulceration and calcinosis, neurovascular aberrations hindering gastrointestinal (GI) motility, progressive painful, incapacitating or immobilizing effects of inflammatory and fibrotic effects on the lungs, skin, articular and periarticular structures, and muscle. SSc-related impairments impede routine activities of daily living (ADLs) and disrupt three critical life areas: work, family, social/leisure, and also impact on psychological well-being. Physical activity and exercise are globally recommended; however, for connective tissue diseases, this guidance carries greater impact on inflammatory disease manifestations, recovery, and cardiovascular health. Exercise, through myogenic and vascular phenomena, naturally targets key pathogenic drivers by downregulating multiple inflammatory and fibrotic pathways in serum and tissue, while increasing circulation and vascular repair. G-FoRSS, The Global Fellowship on Rehabilitation and Exercise in Systemic Sclerosis recognizes the scientific basis of and advocates for education and research of exercise as a systemic and targeted SSc disease-modifying treatment. An overview of biophysiologicalAbstract: Systemic sclerosis (SSc) is a heterogeneous multisystem autoimmune disease whereby its main pathological drivers of disability and damage are vascular injury, inflammatory cell infiltration, and fibrosis. These mechanisms result in diffuse and diverse impairments arising from ischemic circulatory dysfunction leading to painful skin ulceration and calcinosis, neurovascular aberrations hindering gastrointestinal (GI) motility, progressive painful, incapacitating or immobilizing effects of inflammatory and fibrotic effects on the lungs, skin, articular and periarticular structures, and muscle. SSc-related impairments impede routine activities of daily living (ADLs) and disrupt three critical life areas: work, family, social/leisure, and also impact on psychological well-being. Physical activity and exercise are globally recommended; however, for connective tissue diseases, this guidance carries greater impact on inflammatory disease manifestations, recovery, and cardiovascular health. Exercise, through myogenic and vascular phenomena, naturally targets key pathogenic drivers by downregulating multiple inflammatory and fibrotic pathways in serum and tissue, while increasing circulation and vascular repair. G-FoRSS, The Global Fellowship on Rehabilitation and Exercise in Systemic Sclerosis recognizes the scientific basis of and advocates for education and research of exercise as a systemic and targeted SSc disease-modifying treatment. An overview of biophysiological mechanisms of physical activity and exercise are herein imparted for patients, clinicians, and researchers, and applied to SSc disease mechanisms, manifestations, and impairment. A preliminary guidance on exercise in SSc, a research agenda, and the current state of research and outcome measures are set forth. … (more)
- Is Part Of:
- Best practice & research. Volume 35:Issue 3(2021)
- Journal:
- Best practice & research
- Issue:
- Volume 35:Issue 3(2021)
- Issue Display:
- Volume 35, Issue 3 (2021)
- Year:
- 2021
- Volume:
- 35
- Issue:
- 3
- Issue Sort Value:
- 2021-0035-0003-0000
- Page Start:
- Page End:
- Publication Date:
- 2021-09
- Subjects:
- Scleroderma -- Disability -- Exercise -- Physical activity -- Myokine -- Muscle -- Pulmonary rehabilitation -- Interstitial lung disease -- Pulmonary hypertension -- Health-related quality of life
Rheumatology -- Periodicals
Rheumatic Diseases -- Periodicals
Reumatologie
616.723005 - Journal URLs:
- http://www.sciencedirect.com/science/journal/15216942 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.berh.2021.101695 ↗
- Languages:
- English
- ISSNs:
- 1521-6942
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 1942.327831
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 19561.xml